SOMERSET, N.J., Sept. 8, 2010 (GLOBE NEWSWIRE) -- inVentiv Health, a leading provider of end-to-end clinical development, launch and commercialization services to the global healthcare industry, announced today that it has acquired Substrat'Homme SA, commonly known as Star Terre Santé, a leading group of healthcare marketing and communications agencies based in Paris. As part of the inVentiv Communications Global Alliance, Star Terre Santé will provide advertising and promotional services to inVentiv Communications' clients in France and Benelux.
inVentiv Communications, a division of inVentiv Health, and Star Terre Santé have partnered since 2009 to serve the marketing and advertising needs of clients in France, the third-largest pharmaceutical market in the world. Through the transaction, Star Terre Santé will become a wholly owned subsidiary of inVentiv. Financial terms were not disclosed.
Star Terre Santé is comprised of seven healthcare-focused communications disciplines, including Terre Neuve, a leading advertising agency with clients such as Guerbet, Merck Serono, Lilly and Johnson & Johnson.
"Star Terre Santé has built an exceptionally strong reputation for delivering successful communications and marketing solutions to healthcare clients in France and Benelux," said Phil Deschamps, Chief Global Officer of inVentiv Communications. "We are thrilled to formalize our relationship with them and we look forward to continuing to work together to serve our growing base of clients that are marketing products in Europe."
"As we considered the opportunity to expand our business, we wanted to partner with a communications network that brought deep experience and a broad range of resources," said Stéphane Laford, President of Star Terre Santé. "inVentiv's unique focus in healthcare and their breadth of service offerings for pharmaceutical and biotech clients makes them an ideal partner for us."
The inVentiv Communications Global Alliance is a network of healthcare advertising agencies representing all of the major pharmaceutical markets around the world since 2001. With the addition of Star Terre Santé, inVentiv now has marketing operations in 16 major worldwide markets. In addition, Chandler Chicco Companies, also part of inVentiv Communications, has a global network of public relations and communications agencies across 37 global markets.
About inVentiv Health
inVentiv Health, Inc. is a leading, global provider of data-driven, outsourced solutions to the pharmaceutical, life sciences and healthcare industries. inVentiv's full suite of marketing, sales, clinical development and post-approval solutions drive speed and effectiveness across all phases of the product lifecycle, leading to quicker development and superior results throughout product launch and commercialization. inVentiv's client roster consists of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payer companies. For more information, visit .
The inVentiv Health, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4942
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
CONTACT: inVentiv Health, Inc. Investors/Corporate: David Bassin, CFO (732) 537-4804 investor@inventivhealth.com Media: Marcia Frederick (614) 543-6281 mfrederick@inventivhealth.com